Search Results - "Iwasa, S"

Association Between Nonadherence and Transient Hyperuricemia in Pediatric Kidney Transplantation by Morizawa, Y., Satoh, H., Arai, M., Iwasa, S., Sato, A., Fujimoto, K.

“…•Nonadherence among pediatric transplant recipients reduces graft survival.•Transient hyperuricemia is a risk factor for nonadherence after kidney…”
Get full text

Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer by Takahashi, N, Yamada, Y, Furuta, K, Honma, Y, Iwasa, S, Takashima, A, Kato, K, Hamaguchi, T, Shimada, Y

“…Background: Ligands of transmembrane receptor tyrosine kinases have important roles in cell proliferation, survival, migration and differentiation in solid…”
Get full text

Rechargeable batteries with organic radical cathodes by Nakahara, K, Iwasa, S, Satoh, M, Morioka, Y, Iriyama, J, Suguro, M, Hasegawa, E

“…The first known application of stable radicals for energy storage systems is presented. A stable nitroxyl polyradical, poly (2,2,6,6-tetramethylpiperidinyloxy…”
Get full text

583P Effect of infusion rate, premedication, and prophylactic peg-filgrastim treatment on the safety of the liposomal formulation of eribulin (E7389-LF): Results from the expansion part of a phase I study by Iwasa, S., Takahashi, S., Hirao, M., Kato, K., Shitara, K., Sato, Y., Hamakawa, T., Horinouchi, H., Tahara, M., Chin, K., Mizutani, M., Suzuki, T., Takase, T., Matsunaga, R., Mukohara, T.

Get full text

Avelumab (anti–PD-L1) in Japanese patients with advanced gastric or gastroesophageal junction cancer (GC/GEJC): Updated results from the phase Ib JAVELIN solid tumour JPN trial by Doi, T., Iwasa, S., Muro, K., Satoh, T., Hironaka, S., Esaki, T., Nishina, T., Hara, H., Machida, N., Komatsu, Y., Shimada, Y., Otsu, S., Shimizu, S., Chand, V., Watanabe, M.

Get full text

Cisplatin and Etoposide as First-line Chemotherapy for Poorly Differentiated Neuroendocrine Carcinoma of the Hepatobiliary Tract and Pancreas by Iwasa, Satoru, Morizane, Chigusa, Okusaka, Takuji, Ueno, Hideki, Ikeda, Masafumi, Kondo, Shunsuke, Tanaka, Tsutomu, Nakachi, Kohei, Mitsunaga, Shuichi, Kojima, Yasushi, Hagihara, Atsushi, Hiraoka, Nobuyoshi

“…Objective The combination chemotherapy consisting of cisplatin and etoposide, one of the standard regimens for small cell lung cancer, has been widely used to…”
Get full text

CT image features of peritoneal metastasis and outcomes of the advanced gastric cancer patients receiving second-line chemotherapy by Kita, S., Takashima, A., Hirano, H., Aoki, M., Imazeki, H., Ishikawa, M., Shoji, H., Honma, Y., Iwasa, S., Okita, N., Kato, K., Nagashima, K., Boku, N.

Get full text

A phase I trial of the safety and pharmacokinetics of cemiplimab, a human monoclonal antibody to programmed death-1, in Japanese patients with advanced malignancies, including expansion cohorts for patients with non-small-cell lung cancer by Kitano, S., Shimizu, T., Koyama, T., Ebata, T., Iwasa, S., Kondo, S., Shimomura, A., Fujiwara, Y., Yamamoto, N., Baum, C., Li, S., Rietschel, P., Sims, T.

Get full text

Phase I study of IDO1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with atezolizumab in Japanese patients with advanced solid tumors by Yamamoto, N, Fujiwara, Y, Kondo, S, Iwasa, S, Yonemori, K, Shimomura, A, Kitano, S, Shimizu, T, Koyama, T, Ebata, T, Sato, N, Nakai, K, Inatani, M, Tamura, K

Get full text

A novel electrode material for electric double-layer capacitors by Wei, Y.-Z., Fang, B., Iwasa, S., Kumagai, M.

“…In this study, a novel electrode material, modified activated carbon aerogel, has been developed for electric double-layer capacitors (EDLCs). This novel…”
Get full text

A study of the Ce(III)/Ce(IV) redox couple for redox flow battery application by Fang, B, Iwasa, S, Wei, Y, Arai, T, Kumagai, M

“…In this study, the electrochemical behavior of the Ce(III)/Ce(IV) redox couple in sulfuric acid medium with various concentrations and the influence of the…”
Get full text

Impact of UGT1A1 genotype on the efficacy and safety of irinotecan-based chemotherapy in metastatic colorectal cancer (mCRC): A preplanned analysis of the phase III AXEPT trial by Xu, R., Muro, K., Kim, T.W., Park, Y.S., Wang, W., Han, S.-W., Kotaka, M., Deng, Y.-H., Ahn, J.B., Nakamura, M., Ba, Y., Cho, S.-H., Kato, T., Zhang, T., Lee, K.-W., Matsuoka, H., Fang, W.-J., Morita, S., Iwasa, S., Junichi, S.

Get full text

512 A phase 1 study to assess the safety and tolerability of tremelimumab alone and in combination with MEDI4736 in Japanese patients with advanced solid malignancies by Takahashi, Y, Fujikawa, K, Sagawa, T, Fujiwara, Y, Iwasa, S, Yamamoto, N, Sugeno, M, Tsuno, H

Get full text

230 Feasibility study of targeted sequencing-based molecular prescreening of patients for Phase I clinical trials. Trial of Oncopanel for Introduction into Clinical Study Phase 1 (TOPICS-1) by Tanabe, Y, Ichikawa, H, Kohno, T, Yoshida, H, Kubo, T, Iwasa, S, Ochiai, A, Yamamoto, N, Tamura, K

Get full text

1206 Do participants in the phase I trials need to be hospitalized? Domestic but outstanding issues for globalization in Japan by Shimomura, A, Kondo, S, Tanabe, Y, Kitano, S, Iwasa, S, Fujiwara, Y, Tamura, K, Yamamoto, N

Get full text

The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncology by Kubo, T., Sunami, K., Koyama, T., Kitami, M., Fujiwara, Y., Kondo, S., Yonemori, K., Noguchi, E., Morizane, C., Goto, Y., Maejima, A., Iwasa, S., Hamaguchi, T., Kawai, A., Namikawa, K., Arakawa, A., Sugiyama, M., Ohno, M., Yoshida, T., Hiraoka, N., Yoshida, A., Yoshida, M., Nishino, T., Furukawa, E., Narushima, D., Nagai, M., Kato, M., Ichikawa, H., Fujiwara, Y., Kohno, T., Yamamoto, N.

“…Comprehensive genome profiling (CGP) serves as a guide for suitable genomically matched therapies for patients with cancer. However, little is known about the…”
Get full text

314 Phase 1 study of abemaciclib, a CDK 4 and 6 inhibitor, as a single agent for Japanese patients with advanced cancer by Kondo, S, Yamamoto, N, Tamura, K, Tanabe, Y, Iwasa, S, Shimomura, A, Shibasaki, Y, Ogasawara, K, Turner-Jones, K, Mori, J, Asou, H, Michael Chan, E, Fujiwara, Y

Get full text

2301 Phase 2 study of Nivolumab (Anti-PD-1; ONO-4538) in Patients with Esophageal Cancer: Preliminary Report by Takashi, U, Muro, K, Hara, H, Yamaguchi, K, Hironaka, S, Iwasa, S, Kato, K, Kojima, T, Tsushima, T, Yasui, H, Satoh, T, Doki, Y, Ohtsu, A, Hamamoto, Y, Kitagawa, Y

Get full text

2386 Association between the peripheral immune status of granulocytic myeloid-derived suppressor cells and progression-free survival chemotherapy by Shoji, H, Heike, Y, Tada, K, Kitano, S, Nishimura, T, Shimada, Y, Nagashima, K, Ito, A, Honma, Y, Iwasa, S, Okita, N, Takashima, A, Kato, K, Yamada, Y, Boku, N, Hamaguchi, T

Get full text

352 Phase Ia/Ib study of pan-PI3K inhibitor, pictilisib (GDC-0941), in Japanese patients with advanced solid tumors or non-squamous non-small cell lung cancer (JO28645 study) by Yanagitani, N, Horiike, A, Kitazono, S, Tamura, K, Kondo, S, Iwasa, S, Tanabe, Y, Inatani, M, Nakamura, K, Kotani, N, Yamamoto, N, Nishio, M

Get full text